Kyverna Therapeutics, Inc.
KYTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $96,621 | $34,647 | $37,735 | $76,067 |
| Short-Term Investments | $189,358 | $22,896 | $13,587 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,622 | $3,121 | $1,929 | $1,020 |
| Total Curr. Assets | $290,601 | $60,664 | $53,251 | $77,087 |
| Property Plant & Equip (Net) | $10,656 | $10,610 | $12,441 | $7,808 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5,263 | $3,921 | $1,232 | $593 |
| Total NC Assets | $15,919 | $14,531 | $13,673 | $8,401 |
| Other Assets | -$1,875 | $0 | $0 | $0 |
| Total Assets | $304,645 | $75,195 | $66,924 | $85,488 |
| Liabilities | – | – | – | – |
| Payables | $4,624 | $4,358 | $1,451 | $773 |
| Short-Term Debt | $3,940 | $2,920 | $2,277 | $814 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $6,000 |
| Other Curr. Liab. | $25,192 | $12,581 | $8,226 | $8,341 |
| Total Curr. Liab. | $33,756 | $19,859 | $11,954 | $15,928 |
| LT Debt | $4,302 | $6,159 | $8,287 | $4,741 |
| Deferred Rev, NC | $0 | $0 | $0 | $1,025 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $6 | $110,048 |
| Total NC Liab. | $4,302 | $6,159 | $8,293 | $115,814 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8,242 | $9,079 | $10,564 | $5,555 |
| Total Liabilities | $38,058 | $26,018 | $20,247 | $131,742 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $180,574 | $120,674 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$263,520 | -$136,043 | -$75,677 | -$46,784 |
| AOCI | $105 | $4 | -$26 | $0 |
| Other Equity | $530,002 | $4,642 | $1,706 | $530 |
| Total Equity | $266,587 | $49,177 | $46,677 | -$46,254 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $304,645 | $75,195 | $66,924 | $85,488 |
| Net Debt | -$88,379 | -$25,568 | -$27,171 | -$70,512 |